Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459686) titled 'An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis' on March 5.
Study Type: Observational
Primary Sponsor: Pfizer
Condition:
Ulcerative Colitis (UC)
Intervention:
Drug: Velsipity
Recruitment Status: Not recruiting
Date of First Enrollment: March 31, 2026
Target Sample Size: 553
To know more, visit https://clinicaltrials.gov/study/NCT07459686
Published by HT Digital Content Services with permission from Health Daily Digest....